Serina Therapeutics (SER) Other financing activities (2018 - 2025)
Serina Therapeutics (SER) posted Other financing activities of $5000.0 for Q4 2025, down 37.5% sequentially from $8000.0 in Q3 2025, and up 100.1% YoY from $2498.7 in Q4 2024.
Serina Therapeutics (SER) Other financing activities (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Other financing activities for 7 years, with the latest figure at $5000.0 in Q4 2025.
- Quarterly Other financing activities rose 100.1% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15000.0 (up 25.0% YoY) and the FY2025 annual result came in at $15000.0, up 25.0% from the prior year.
- Other financing activities eased to $5000.0 in Q4 2025 per SER's latest filing, from $8000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $5.0 million in Q3 2024 and troughed at -$5.0 million in Q4 2024.
- A 4-year average of -$22400.0 and a median of $2500.0 in 2024 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2024: Other financing activities sank 190.0% in 2021, then surged 498500.0% in 2024.
- Over 4 years, Other financing activities stood at -$2.2 million in 2021, then soared by 99.96% to -$1000.0 in 2023, then sank by 497500.0% to -$5.0 million in 2024, then surged by 100.1% to $5000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $5000.0, $8000.0, and $1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -4.98 Mn |
| Dec 31, 2024 | -4.98 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2021 | -2.25 Mn |
| Jun 30, 2021 | -2.25 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Mar 31, 2021 | 2.00 Mn |